Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Bruchfeld

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
Arthritis Research & Therapy|February 22, 2012
Renal expression and serum levels of high mobility group box 1 protein in lupus nephritisAgneta Zickert, Karin Palmblad, Birgitta Sundelin, et al.
Clinical Kidney Journal|May 2, 2022
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy-an open-label pilot studyAnnette Bruchfeld, Hasan Magin, Patrick Nachman, et al.
Molecular Medicine (Cambridge, Mass.)|March 5, 2008
High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD)Annette Bruchfeld, Abdul Rashid Qureshi, Bengt Lindholm, et al.
Clinical Kidney Journal|September 29, 2015
Cholinergic anti-inflammatory pathway activity in dialysis patients: a role for neuroimmunomodulation?Marie Hilderman, Abdul R Qureshi, Yousef Al-Abed, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 4, 2021
Observational study of risk factors associated with clinical outcome among elderly kidney transplant recipients in Sweden - a decade of follow-upHelen Erlandsson, Abdul Rashid Qureshi, Tim Scholz, et al.
Clinical Kidney Journal|June 1, 2023
Challenges of defining renal response in ANCA-associated vasculitis: call to action?Balazs Odler, Annette Bruchfeld, Jennifer Scott, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2023
Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxisMartin Windpessl, Myrto Kostopoulou, Richard Conway, et al.
Frontiers in Medicine|November 2, 2023
Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitidesAsta Dogg Jonasdottir, Milena Manojlovic, Jelena Vojinovic, et al.
Arthritis Research & Therapy|August 14, 2021
First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitisFrancesca Faustini, Nicky Dunn, Nastya Kharlamova, et al.
Kidney International Reports|October 27, 2025
Reporting Quality of Randomized Controlled Trials in Antineutrophil Cytoplasmic Autoantibody-Associated VasculitisVanja Ivković, Annette Bruchfeld, Lauren Floyd, et al.
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Arthritis Research & Therapy|February 22, 2012
Renal expression and serum levels of high mobility group box 1 protein in lupus nephritisAgneta Zickert, Karin Palmblad, Birgitta Sundelin, et al.
Clinical Kidney Journal|May 2, 2022
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy-an open-label pilot studyAnnette Bruchfeld, Hasan Magin, Patrick Nachman, et al.
Molecular Medicine (Cambridge, Mass.)|March 5, 2008
High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD)Annette Bruchfeld, Abdul Rashid Qureshi, Bengt Lindholm, et al.
Clinical Kidney Journal|September 29, 2015
Cholinergic anti-inflammatory pathway activity in dialysis patients: a role for neuroimmunomodulation?Marie Hilderman, Abdul R Qureshi, Yousef Al-Abed, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 4, 2021
Observational study of risk factors associated with clinical outcome among elderly kidney transplant recipients in Sweden - a decade of follow-upHelen Erlandsson, Abdul Rashid Qureshi, Tim Scholz, et al.
Clinical Kidney Journal|June 1, 2023
Challenges of defining renal response in ANCA-associated vasculitis: call to action?Balazs Odler, Annette Bruchfeld, Jennifer Scott, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2023
Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxisMartin Windpessl, Myrto Kostopoulou, Richard Conway, et al.
Frontiers in Medicine|November 2, 2023
Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitidesAsta Dogg Jonasdottir, Milena Manojlovic, Jelena Vojinovic, et al.
Arthritis Research & Therapy|August 14, 2021
First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitisFrancesca Faustini, Nicky Dunn, Nastya Kharlamova, et al.
Kidney International Reports|October 27, 2025
Reporting Quality of Randomized Controlled Trials in Antineutrophil Cytoplasmic Autoantibody-Associated VasculitisVanja Ivković, Annette Bruchfeld, Lauren Floyd, et al.
Pageof 16